Evidence map›Paper›PMID 24215482›Full record

ArticlePhotochemistry and photobiology

Hydrogel-forming and dissolving microneedles for enhanced delivery of photosensitizers and precursors.

Ryan F Donnelly, Desmond I J Morrow, Maelíosa T C McCrudden, Ahlam Zaid Alkilani, Eva M Vicente-Pérez, Conor O'Mahony, Patricia González-Vázquez, Paul A McCarron, A David Woolfson

Open access · greenAbstract read
In one paragraph

Article in Photochemistry and photobiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 107 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Microneedles forMaterials today. Bio · 2023
    Review
  9. Review
  10. Review
  11. Review
  12. An update on coating/manufacturing techniques of microneedles.Drug delivery and translational research · 2018
    Review
  13. Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Ryan F DonnellySchool of Pharmacy, Queen's University Belfast, Medical Biology Centre, Belfast, UK.
Desmond I J Morrow
Maelíosa T C McCrudden
Ahlam Zaid Alkilani
Eva M Vicente-Pérez
Conor O'Mahony
Patricia González-Vázquez
Paul A McCarron
A David Woolfson
Queen's University Belfast · GBUniversity College Cork · IEUniversity of Ulster · GB

Funding

Biotechnology and Biological Sciences Research Council BB/E020534/1Biotechnology and Biological Sciences Research Council BB/FOF/287Wellcome Trust 094085Wellcome Trust WT094085MA
6 · The paper itself

Abstract

We present "one-step application" dissolving and hydrogel-forming microneedle arrays (MN) for enhanced delivery of photosensitizers/precursors. MN (280 μm) prepared from 20% w/w poly(methylvinylether/maelic acid) and cross-linked with glycerol by esterification to form hydrogels upon skin insertion, or allowed to dissolve rapidly in skin, were combined with patches containing 19 mg cm(-2) of 5-aminolevulinic acid (ALA) or meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate (TMP) for drug delivery. Both MN types were mechanically robust, with compression forces of 20.0 N only causing height reductions of 14%. Application forces as low as 8.0 N per array allowed >95% of the MN in each array type to penetrate excised porcine skin, with the MN penetrating to approximately 220 μm. MN significantly enhanced transdermal delivery of ALA and TMP in vitro, with the hydrogel-forming system comparable with the dissolving system for ALA delivery (approximately 3000 nmol cm(-2) over 6 h), but superior for delivery of the much larger TMP molecule (approximately 14 nmol cm(-2) over 24 h, compared to 0.15 nmol cm(-2)). As this technology clearly has potential in enhanced photodynamic therapy of neoplastic skin lesions, we are currently planning animal studies, to be followed by preliminary human evaluations. GMP manufacturing scale-up is ongoing.

Indexed as

HydrogelsNeedlesAnimalsPhotosensitizing AgentsSolubilitySwineHydrogelsPhotosensitizing Agents

Identifiers

PMID24215482
PMCPMC4119997
OpenAlexW2001223819

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.